Ansell B M, Hall M A, Moran H, Fowler P D
J Int Med Res. 1977;5 Suppl 2:52-8.
Juvenile ankylosing spondylitis, as a clinical entity, is outlined. A double-blind trial compared Safapryn and Butazolidin, each given for 3 months, for 15 treatment periods in 11 patients. No differences were shown, but the study highlighted the problems of assessing this condition, and some comments are made, hopefully, to guide further investigators in this field.
本文概述了青少年强直性脊柱炎这一临床实体。一项双盲试验对11名患者进行了15个治疗周期的研究，比较了Safapryn和保泰松，每种药物给药3个月。结果未显示出差异，但该研究突出了评估这种疾病的问题，并提出了一些意见，希望能为该领域的进一步研究人员提供指导。
